{"entity":{"type":"insider","cik":"0001571659","url":"/insider/0001571659","json_url":"/insider/0001571659.json","name":"Xstelos Corp.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":8,"first":"2019-01-09","last":"2021-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Xstelos Corp.","source":"filing","n_filings":8,"first_seen":"2019-01-09","last_seen":"2021-08-17"}],"transactions":[{"id":5492582,"accession":"0000921895-21-002138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-21-002138","line_url":"/filing/0000921895-21-002138","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Myrexis, Inc.; COUCHMAN JONATHAN; Xstelos Corp.; Couchman Family Fund","owner_display_name":"Myrexis, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107500.0,"shares_display":"107,500","price_per_share":0.3898,"price_display":"0.39","price_state":"stated","total_value":41903.5,"total_display":"41,903.50","total_whole":"41,904","shares_owned_after":2043024.0,"shares_owned_after_display":"2,043,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-13","filed_date":"2021-08-17","scope":"insider","n_lines":2},{"id":2386303,"accession":"0000921895-20-002331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-20-002331","line_url":"/filing/0000921895-20-002331#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_display_name":"HARPER ASSET MANAGEMENT LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.1913,"price_display":"0.19","price_state":"stated","total_value":4782.5,"total_display":"4,782.50","total_whole":"4,783","shares_owned_after":1590194.0,"shares_owned_after_display":"1,590,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-25","filed_date":"2020-08-26","scope":"insider"},{"id":2386298,"accession":"0000921895-20-002331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-002331","line_url":"/filing/0000921895-20-002331#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_display_name":"HARPER ASSET MANAGEMENT LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52100.0,"shares_display":"52,100","price_per_share":0.1834,"price_display":"0.18","price_state":"stated","total_value":9555.14,"total_display":"9,555.14","total_whole":"9,555","shares_owned_after":1615194.0,"shares_owned_after_display":"1,615,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-26","scope":"insider"},{"id":2134898,"accession":"0000921895-20-002115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-002115","line_url":"/filing/0000921895-20-002115#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"HARPER ASSET MANAGEMENT LLC; Myrexis, Inc.; Couchman Family Fund; Xstelos Corp.; Pearce Michael Cooper; Harper Brian James; COUCHMAN JONATHAN","owner_display_name":"HARPER ASSET MANAGEMENT LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":506292.0,"shares_display":"506,292","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":101258.4,"total_display":"101,258.40","total_whole":"101,258","shares_owned_after":2100524.0,"shares_owned_after_display":"2,100,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-06","scope":"insider"},{"id":9208948,"accession":"0000921895-20-000958","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-20-000958","line_url":"/filing/0000921895-20-000958#line-4","is_derivative":false,"issuer_cik":"0001265094","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0001265094","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Myrexis, Inc.; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160785.0,"shares_display":"160,785","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":22509.9,"total_display":"22,509.90","total_whole":"22,510","shares_owned_after":633264.0,"shares_owned_after_display":"633,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-31","scope":"insider"},{"id":2974037,"accession":"0001193805-20-000418","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-20-000418","line_url":"/filing/0001193805-20-000418#line-4","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160785.0,"shares_display":"160,785","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":22509.9,"total_display":"22,509.90","total_whole":"22,510","shares_owned_after":633264.0,"shares_owned_after_display":"633,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-27","scope":"insider"},{"id":9208949,"accession":"0000921895-20-000958","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-20-000958","line_url":"/filing/0000921895-20-000958#line-3","is_derivative":false,"issuer_cik":"0001265094","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0001265094","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Myrexis, Inc.; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":469551.0,"shares_display":"469,551","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":65737.14,"total_display":"65,737.14","total_whole":"65,737","shares_owned_after":472479.0,"shares_owned_after_display":"472,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-31","scope":"insider"},{"id":2974033,"accession":"0001193805-20-000418","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-20-000418","line_url":"/filing/0001193805-20-000418#line-3","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":469551.0,"shares_display":"469,551","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":65737.14,"total_display":"65,737.14","total_whole":"65,737","shares_owned_after":472479.0,"shares_owned_after_display":"472,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-27","scope":"insider"},{"id":9208950,"accession":"0000921895-20-000958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-20-000958","line_url":"/filing/0000921895-20-000958#line-2","is_derivative":false,"issuer_cik":"0001265094","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0001265094","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Myrexis, Inc.; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2678.0,"shares_display":"2,678","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":374.92,"total_display":"374.92","total_whole":"375","shares_owned_after":2928.0,"shares_owned_after_display":"2,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-31","scope":"insider"},{"id":2974030,"accession":"0001193805-20-000418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-20-000418","line_url":"/filing/0001193805-20-000418#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2678.0,"shares_display":"2,678","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":374.92,"total_display":"374.92","total_whole":"375","shares_owned_after":2928.0,"shares_owned_after_display":"2,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-27","scope":"insider"},{"id":9208947,"accession":"0000921895-20-000958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-20-000958","line_url":"/filing/0000921895-20-000958#line-1","is_derivative":false,"issuer_cik":"0001265094","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0001265094","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Myrexis, Inc.; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19709.0,"shares_display":"19,709","price_per_share":0.135,"price_display":"0.14","price_state":"stated","total_value":2660.715,"total_display":"2,660.72","total_whole":"2,661","shares_owned_after":1594232.0,"shares_owned_after_display":"1,594,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-31","scope":"insider"},{"id":2974028,"accession":"0001193805-20-000418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-000418","line_url":"/filing/0001193805-20-000418#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"COUCHMAN JONATHAN; Couchman Family Fund; Xstelos Corp.","owner_display_name":"COUCHMAN JONATHAN","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19709.0,"shares_display":"19,709","price_per_share":0.135,"price_display":"0.14","price_state":"stated","total_value":2660.715,"total_display":"2,660.72","total_whole":"2,661","shares_owned_after":1594232.0,"shares_owned_after_display":"1,594,232","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-27","scope":"insider"},{"id":7910750,"accession":"0000921895-19-000500","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-19-000500","line_url":"/filing/0000921895-19-000500","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51000.0,"shares_display":"51,000","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":12750.0,"total_display":"12,750.00","total_whole":"12,750","shares_owned_after":4697166.0,"shares_owned_after_display":"4,697,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-11","filed_date":"2019-02-14","scope":"insider","n_lines":6},{"id":8508280,"accession":"0000921895-19-000048","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-18","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":510.0,"total_display":"510.00","total_whole":"510","shares_owned_after":4681666.0,"shares_owned_after_display":"4,681,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"},{"id":8508277,"accession":"0000921895-19-000048","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-17","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":637.5,"total_display":"637.50","total_whole":"638","shares_owned_after":4679666.0,"shares_owned_after_display":"4,679,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-09","scope":"insider"},{"id":8508275,"accession":"0000921895-19-000048","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-16","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":1147.5,"total_display":"1,147.50","total_whole":"1,148","shares_owned_after":4677166.0,"shares_owned_after_display":"4,677,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-09","scope":"insider"},{"id":8508270,"accession":"0000921895-19-000048","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-15","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312523.0,"shares_display":"312,523","price_per_share":0.2691,"price_display":"0.27","price_state":"stated","total_value":84099.9393,"total_display":"84,099.94","total_whole":"84,100","shares_owned_after":1559523.0,"shares_owned_after_display":"1,559,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2019-01-09","scope":"insider"},{"id":8508266,"accession":"0000921895-19-000048","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-14","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":213189.0,"shares_display":"213,189","price_per_share":0.2365,"price_display":"0.24","price_state":"stated","total_value":50419.1985,"total_display":"50,419.20","total_whole":"50,419","shares_owned_after":1247000.0,"shares_owned_after_display":"1,247,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2019-01-09","scope":"insider"},{"id":8508257,"accession":"0000921895-19-000048","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-13","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15261.0,"shares_display":"15,261","price_per_share":0.23,"price_display":"0.23","price_state":"stated","total_value":3510.03,"total_display":"3,510.03","total_whole":"3,510","shares_owned_after":1033811.0,"shares_owned_after_display":"1,033,811","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2019-01-09","scope":"insider"},{"id":8508252,"accession":"0000921895-19-000048","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-12","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":550.0,"total_display":"550.00","total_whole":"550","shares_owned_after":1018550.0,"shares_owned_after_display":"1,018,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2019-01-09","scope":"insider"},{"id":8508248,"accession":"0000921895-19-000048","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-11","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":242.0,"total_display":"242.00","total_whole":"242","shares_owned_after":1016050.0,"shares_owned_after_display":"1,016,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2019-01-09","scope":"insider"},{"id":8508245,"accession":"0000921895-19-000048","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-10","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":99.0,"total_display":"99.00","total_whole":"99","shares_owned_after":1014950.0,"shares_owned_after_display":"1,014,950","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2019-01-09","scope":"insider"},{"id":8508240,"accession":"0000921895-19-000048","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-9","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42450.0,"shares_display":"42,450","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":9339.0,"total_display":"9,339.00","total_whole":"9,339","shares_owned_after":1014500.0,"shares_owned_after_display":"1,014,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2019-01-09","scope":"insider"},{"id":8508237,"accession":"0000921895-19-000048","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-8","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40050.0,"shares_display":"40,050","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":8811.0,"total_display":"8,811.00","total_whole":"8,811","shares_owned_after":972050.0,"shares_owned_after_display":"972,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-21","filed_date":"2019-01-09","scope":"insider"},{"id":8508233,"accession":"0000921895-19-000048","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-7","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.2196,"price_display":"0.22","price_state":"stated","total_value":3294.0,"total_display":"3,294.00","total_whole":"3,294","shares_owned_after":932000.0,"shares_owned_after_display":"932,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2019-01-09","scope":"insider"},{"id":8508229,"accession":"0000921895-19-000048","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-6","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":525.0,"total_display":"525.00","total_whole":"525","shares_owned_after":917000.0,"shares_owned_after_display":"917,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2019-01-09","scope":"insider"},{"id":8508225,"accession":"0000921895-19-000048","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-5","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":914500.0,"shares_owned_after_display":"914,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2019-01-09","scope":"insider"},{"id":8508221,"accession":"0000921895-19-000048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-4","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.21,"price_display":"0.21","price_state":"stated","total_value":21000.0,"total_display":"21,000.00","total_whole":"21,000","shares_owned_after":814500.0,"shares_owned_after_display":"814,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-12","filed_date":"2019-01-09","scope":"insider"},{"id":8508217,"accession":"0000921895-19-000048","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-3","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67200.0,"shares_display":"67,200","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":17472.0,"total_display":"17,472.00","total_whole":"17,472","shares_owned_after":4672666.0,"shares_owned_after_display":"4,672,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2019-01-09","scope":"insider"},{"id":8508213,"accession":"0000921895-19-000048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-2","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8800.0,"shares_display":"8,800","price_per_share":0.2588,"price_display":"0.26","price_state":"stated","total_value":2277.44,"total_display":"2,277.44","total_whole":"2,277","shares_owned_after":4605466.0,"shares_owned_after_display":"4,605,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2019-01-09","scope":"insider"},{"id":8508208,"accession":"0000921895-19-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-000048","line_url":"/filing/0000921895-19-000048#line-1","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20600.0,"shares_display":"20,600","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":5253.0,"total_display":"5,253.00","total_whole":"5,253","shares_owned_after":4596666.0,"shares_owned_after_display":"4,596,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2019-01-09","scope":"insider"},{"id":8697197,"accession":"0000921895-19-000047","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-30","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3671.0,"shares_display":"3,671","price_per_share":0.255,"price_display":"0.26","price_state":"stated","total_value":936.105,"total_display":"936.10","total_whole":"936","shares_owned_after":4576066.0,"shares_owned_after_display":"4,576,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2019-01-09","scope":"insider"},{"id":8697192,"accession":"0000921895-19-000047","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-29","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":384100.0,"shares_display":"384,100","price_per_share":0.2575,"price_display":"0.26","price_state":"stated","total_value":98905.75,"total_display":"98,905.75","total_whole":"98,906","shares_owned_after":4572395.0,"shares_owned_after_display":"4,572,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2019-01-09","scope":"insider"},{"id":8697191,"accession":"0000921895-19-000047","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-28","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2470.0,"total_display":"2,470.00","total_whole":"2,470","shares_owned_after":4188295.0,"shares_owned_after_display":"4,188,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2019-01-09","scope":"insider"},{"id":8697188,"accession":"0000921895-19-000047","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-27","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40316.0,"shares_display":"40,316","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":10482.16,"total_display":"10,482.16","total_whole":"10,482","shares_owned_after":4178795.0,"shares_owned_after_display":"4,178,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2019-01-09","scope":"insider"},{"id":8697185,"accession":"0000921895-19-000047","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-26","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8255.0,"shares_display":"8,255","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2146.3,"total_display":"2,146.30","total_whole":"2,146","shares_owned_after":4138479.0,"shares_owned_after_display":"4,138,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2019-01-09","scope":"insider"},{"id":8697182,"accession":"0000921895-19-000047","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-25","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":112.0,"shares_display":"112","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":29.12,"total_display":"29.12","total_whole":"29","shares_owned_after":4130224.0,"shares_owned_after_display":"4,130,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-27","filed_date":"2019-01-09","scope":"insider"},{"id":8697179,"accession":"0000921895-19-000047","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-24","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26655.0,"shares_display":"26,655","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":6930.3,"total_display":"6,930.30","total_whole":"6,930","shares_owned_after":4130112.0,"shares_owned_after_display":"4,130,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-26","filed_date":"2019-01-09","scope":"insider"},{"id":8697176,"accession":"0000921895-19-000047","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-23","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11368.0,"shares_display":"11,368","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2955.68,"total_display":"2,955.68","total_whole":"2,956","shares_owned_after":4103457.0,"shares_owned_after_display":"4,103,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-24","filed_date":"2019-01-09","scope":"insider"},{"id":8697173,"accession":"0000921895-19-000047","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-22","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":355.0,"shares_display":"355","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":92.3,"total_display":"92.30","total_whole":"92","shares_owned_after":4092089.0,"shares_owned_after_display":"4,092,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-20","filed_date":"2019-01-09","scope":"insider"},{"id":8697170,"accession":"0000921895-19-000047","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-21","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":635.0,"shares_display":"635","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":165.1,"total_display":"165.10","total_whole":"165","shares_owned_after":4091734.0,"shares_owned_after_display":"4,091,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-11","filed_date":"2019-01-09","scope":"insider"},{"id":8697165,"accession":"0000921895-19-000047","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-20","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":728.0,"total_display":"728.00","total_whole":"728","shares_owned_after":4091099.0,"shares_owned_after_display":"4,091,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-10","filed_date":"2019-01-09","scope":"insider"},{"id":8697162,"accession":"0000921895-19-000047","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-19","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21975.0,"shares_display":"21,975","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":5713.5,"total_display":"5,713.50","total_whole":"5,714","shares_owned_after":4088299.0,"shares_owned_after_display":"4,088,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2019-01-09","scope":"insider"},{"id":8697160,"accession":"0000921895-19-000047","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000921895-19-000047","line_url":"/filing/0000921895-19-000047#line-18","is_derivative":false,"issuer_cik":"0000727510","issuer_name":"ENZON PHARMACEUTICALS, INC.","issuer_ticker":"ENZN","issuer_name_source":null,"issuer_url":"/issuer/0000727510","owner_cik":null,"owner_name":"Couchman Family Fund; COUCHMAN JONATHAN; Xstelos Corp.","owner_display_name":"Couchman Family Fund","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":5200.0,"total_display":"5,200.00","total_whole":"5,200","shares_owned_after":4066324.0,"shares_owned_after_display":"4,066,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-03","filed_date":"2019-01-09","scope":"insider"}],"collapsed":true,"next_cursor":"2018-07-03|8697160","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000727510","name":"ENZON PHARMACEUTICALS, INC.","url":"/issuer/0000727510","role":"Ten percent owner, Other","n_filings":8,"first_seen":"2019-01-09","last_seen":"2021-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571659","retrieved_at":"2026-08-23T05:12:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}